Trial Profile
Three-month Outcome of Ziv-aflibercept for Diabetic Macular Edema
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 11 Jul 2017
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 19 May 2016 New trial record